Patients with moderate to severe degrees of Henoch-Schönlein purpura (HSP) nephritis receive high-dose intravenous methylprednisolone pulse therapy (IMPT). Although the regimen is generally safe and effective, various complications occasionally develop. administration of excessive corticosteroid can induce urinary potassium wasting leading to hypokalemia. Polyuria, one of the complications of hypokalemia, is related to both increased thirst and mild nephrogenic diabetes insipidus. And hypokalemia itself also impairs the maximal renal urinary concentration ability. Although polyuria or nocturia after IMPT is not common, it is correctable immediately by oral potassium supplementation. Therefore, during IMPT, careful history taking of nocturia as well as monitoring urine volume, serum and urine potassium level at regular follow-up are necessary because even mild hypokalemia can provoke urine concentrating ability defect. We experienced a case of 11 year-old boy with HSP nephritis who suffered from hypokalemiainduced polyuria with nocturia right after IMPT. (J Korean Soc Pediatr Nephrol 2010;14:230-235) 
Introduction
High dose intravenous methylprednisolone pulse therapy (IMPT) has been used for the treatment of moderate to severe degrees of Henoch-Schönlein purpura (HSP) nephritis [1] . Patric pulses every other day [6] . Also, the therapy is often used in several rheumatologic conditions such as systemic lupus erythematosus, rheumatoid arthritis, and pemphigus vulgaris and also in treatment for acute rejection after organ transplantation [3] [4] [5] . However, it has been vomiting, cataracts, hypokalemia, and infections [2, 5] .
Herein we report our experience with an 11-year-old boy who suffered from nocturia and polyuria after receiving high-dose IMPT because of moderate degrees of HSP nephritis.
Case report
An 11-year-old boy was diagnosed with 
Discussion
There are few reports on development of polyuria after IMPT. But, it has already been known that IMPT can cause hypokalemia from urinary potassium wasting [7] and that hypokalemia per se can induce mild polyuria as well [8] .
A normal subject can, in the presence of potassium depletion, lower urinary potassium excretion below 25 to 30 meq per day; values Second day of high dose methylpredisolone pulse therapy Abbreviations: BUN, blood urea nitrogen; Cr, creatinine; Osm (S), serum osmolarity; Urine S.G, urine specific gravity; Osm(U), urine osmolarity; Cr(U), urine creatinine 대한소아신장학회지 : 제 14 권 제 2 호 년 2010 above this level reflect at least a contribution from urinary potassium wasting [9] . However, potassium wasting may be minimized or even masked if sodium and water delivery to the distal potassium secretory site is minimized by underlying volume depletion [10] . Thus, urinary sodium excretion should be above 30 to 40 meq per day to avoid this problem [11] . In this case, excessive corticosteroids by administering high dose of methylprednisolone seemed to induce increased urinary potassium losses leading to mild hypokalemia. TamezPérez et al. [13] reported that the prevalence of mild hypokalemia in 110 patients with IMPT
(1 g/day for three consecutive days) was 17.27 % and no cases of severe hypokalemia occurred.
The development of mild polyuria, averaging 2 to 3 liters per day is one of complications of hypokalemia [8] . The polyuria is related to both increased thirst and mild nephrogenic diabetes insipidus. Increased thirst is associated with increased central nervous system levels of angiotensin II, a hormone that, besides its other effects, regulates thirst. Hypokalemia also impairs the kidney s ability to concentrate ' the urine maximally [8] . This appears to occur because hypokalemia causes defective activation of renal adenylate cyclase, preventing antidiuretic hormone-stimulated urinary concentration [14] . Several other mechanisms of K + deprivation-induced polyuria have been proposed to explain the defect in urinary concentrating ability in K + depletion, including prosta-glandin overproduction [15] , primary polydipsia [16] , altered ADH release by the posterior pituitary gland [17] , abnormal medullary oxidative metabolism [18] , and reduced medullary solute [19] .
For the first time, we experienced the development of polyuria and noctuira after IMPT. 
